251 related articles for article (PubMed ID: 33958598)
1. Metabolic modelling reveals broad changes in gut microbial metabolism in inflammatory bowel disease patients with dysbiosis.
Heinken A; Hertel J; Thiele I
NPJ Syst Biol Appl; 2021 May; 7(1):19. PubMed ID: 33958598
[TBL] [Abstract][Full Text] [Related]
2. Dynamics of metatranscription in the inflammatory bowel disease gut microbiome.
Schirmer M; Franzosa EA; Lloyd-Price J; McIver LJ; Schwager R; Poon TW; Ananthakrishnan AN; Andrews E; Barron G; Lake K; Prasad M; Sauk J; Stevens B; Wilson RG; Braun J; Denson LA; Kugathasan S; McGovern DPB; Vlamakis H; Xavier RJ; Huttenhower C
Nat Microbiol; 2018 Mar; 3(3):337-346. PubMed ID: 29311644
[TBL] [Abstract][Full Text] [Related]
3. Microbiome and metabolome in inflammatory bowel disease.
Upadhyay KG; Desai DC; Ashavaid TF; Dherai AJ
J Gastroenterol Hepatol; 2023 Jan; 38(1):34-43. PubMed ID: 36287112
[TBL] [Abstract][Full Text] [Related]
4. Systematic assessment of secondary bile acid metabolism in gut microbes reveals distinct metabolic capabilities in inflammatory bowel disease.
Heinken A; Ravcheev DA; Baldini F; Heirendt L; Fleming RMT; Thiele I
Microbiome; 2019 May; 7(1):75. PubMed ID: 31092280
[TBL] [Abstract][Full Text] [Related]
5. The Roles of Inflammation, Nutrient Availability and the Commensal Microbiota in Enteric Pathogen Infection.
Stecher B
Microbiol Spectr; 2015 Jun; 3(3):. PubMed ID: 26185088
[TBL] [Abstract][Full Text] [Related]
6. Gut dysbiosis and paediatric Crohn's disease.
Brusaferro A; Cavalli E; Farinelli E; Cozzali R; Principi N; Esposito S
J Infect; 2019 Jan; 78(1):1-7. PubMed ID: 30336176
[TBL] [Abstract][Full Text] [Related]
7. Dysbiosis in Inflammatory Bowel Disease: Pathogenic Role and Potential Therapeutic Targets.
Santana PT; Rosas SLB; Ribeiro BE; Marinho Y; de Souza HSP
Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35408838
[TBL] [Abstract][Full Text] [Related]
8. Faecal metabolome and its determinants in inflammatory bowel disease.
Vich Vila A; Hu S; Andreu-Sánchez S; Collij V; Jansen BH; Augustijn HE; Bolte LA; Ruigrok RAAA; Abu-Ali G; Giallourakis C; Schneider J; Parkinson J; Al-Garawi A; Zhernakova A; Gacesa R; Fu J; Weersma RK
Gut; 2023 Aug; 72(8):1472-1485. PubMed ID: 36958817
[TBL] [Abstract][Full Text] [Related]
9. Development of the intestinal microbiome in cystic fibrosis in early life.
Price CE; Hampton TH; Valls RA; Barrack KE; O'Toole GA; Madan JC; Coker MO
mSphere; 2023 Aug; 8(4):e0004623. PubMed ID: 37404016
[TBL] [Abstract][Full Text] [Related]
10. Correlation of diet, microbiota and metabolite networks in inflammatory bowel disease.
Weng YJ; Gan HY; Li X; Huang Y; Li ZC; Deng HM; Chen SZ; Zhou Y; Wang LS; Han YP; Tan YF; Song YJ; Du ZM; Liu YY; Wang Y; Qin N; Bai Y; Yang RF; Bi YJ; Zhi FC
J Dig Dis; 2019 Sep; 20(9):447-459. PubMed ID: 31240835
[TBL] [Abstract][Full Text] [Related]
11. Urinary metabolic insights into host-gut microbial interactions in healthy and IBD children.
Martin FP; Su MM; Xie GX; Guiraud SP; Kussmann M; Godin JP; Jia W; Nydegger A
World J Gastroenterol; 2017 May; 23(20):3643-3654. PubMed ID: 28611517
[TBL] [Abstract][Full Text] [Related]
12. Characteristics of Faecal Microbiota in Paediatric Crohn's Disease and Their Dynamic Changes During Infliximab Therapy.
Wang Y; Gao X; Ghozlane A; Hu H; Li X; Xiao Y; Li D; Yu G; Zhang T
J Crohns Colitis; 2018 Feb; 12(3):337-346. PubMed ID: 29194468
[TBL] [Abstract][Full Text] [Related]
13. Dynamics of the human gut microbiome in inflammatory bowel disease.
Halfvarson J; Brislawn CJ; Lamendella R; Vázquez-Baeza Y; Walters WA; Bramer LM; D'Amato M; Bonfiglio F; McDonald D; Gonzalez A; McClure EE; Dunklebarger MF; Knight R; Jansson JK
Nat Microbiol; 2017 Feb; 2():17004. PubMed ID: 28191884
[TBL] [Abstract][Full Text] [Related]
14. Overrepresentation of Enterobacteriaceae and
Khorsand B; Asadzadeh Aghdaei H; Nazemalhosseini-Mojarad E; Nadalian B; Nadalian B; Houri H
Front Cell Infect Microbiol; 2022; 12():1015890. PubMed ID: 36268225
[TBL] [Abstract][Full Text] [Related]
15. Increased abundance of proteobacteria in aggressive Crohn's disease seven years after diagnosis.
Vester-Andersen MK; Mirsepasi-Lauridsen HC; Prosberg MV; Mortensen CO; Träger C; Skovsen K; Thorkilgaard T; Nøjgaard C; Vind I; Krogfelt KA; Sørensen N; Bendtsen F; Petersen AM
Sci Rep; 2019 Sep; 9(1):13473. PubMed ID: 31530835
[TBL] [Abstract][Full Text] [Related]
16. Metaproteomics reveals persistent and phylum-redundant metabolic functional stability in adult human gut microbiomes of Crohn's remission patients despite temporal variations in microbial taxa, genomes, and proteomes.
Blakeley-Ruiz JA; Erickson AR; Cantarel BL; Xiong W; Adams R; Jansson JK; Fraser CM; Hettich RL
Microbiome; 2019 Feb; 7(1):18. PubMed ID: 30744677
[TBL] [Abstract][Full Text] [Related]
17. Deciphering Gut Microbiota Dysbiosis and Corresponding Genetic and Metabolic Dysregulation in Psoriasis Patients Using Metagenomics Sequencing.
Xiao S; Zhang G; Jiang C; Liu X; Wang X; Li Y; Cheng M; Lv H; Xian F; Guo X; Tan Y
Front Cell Infect Microbiol; 2021; 11():605825. PubMed ID: 33869074
[TBL] [Abstract][Full Text] [Related]
18. Roles for Intestinal Bacteria, Viruses, and Fungi in Pathogenesis of Inflammatory Bowel Diseases and Therapeutic Approaches.
Sartor RB; Wu GD
Gastroenterology; 2017 Feb; 152(2):327-339.e4. PubMed ID: 27769810
[TBL] [Abstract][Full Text] [Related]
19. Opportunistic detection of Fusobacterium nucleatum as a marker for the early gut microbial dysbiosis.
Huh JW; Roh TY
BMC Microbiol; 2020 Jul; 20(1):208. PubMed ID: 32660414
[TBL] [Abstract][Full Text] [Related]
20. Gut microbiome structure and metabolic activity in inflammatory bowel disease.
Franzosa EA; Sirota-Madi A; Avila-Pacheco J; Fornelos N; Haiser HJ; Reinker S; Vatanen T; Hall AB; Mallick H; McIver LJ; Sauk JS; Wilson RG; Stevens BW; Scott JM; Pierce K; Deik AA; Bullock K; Imhann F; Porter JA; Zhernakova A; Fu J; Weersma RK; Wijmenga C; Clish CB; Vlamakis H; Huttenhower C; Xavier RJ
Nat Microbiol; 2019 Feb; 4(2):293-305. PubMed ID: 30531976
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
